Dr. Marcin Imielinski

Weill Cornell Medicine and New York Genome Center researchers, in collaboration with Oxford Nanopore Technologies, have developed a new method to assess on a large scale the three-dimensional structure of the human genome, or how the genome folds.

Dr. Marcin Imielinski and Dr. Elena Piskounova were awarded the 2021 Pershing Square Sohn Prize for Young Investigators in Cancer Research.

Two distinct diagnostic tests, a host/pathogen RNA sequencing platform, and spatially-resolved tissue mapping tools were created by a multidisciplinary team of Weill Cornell Medicine and NewYork-Presbyterian Hospital-led researchers and used to map SARS-CoV-2 infections at the height of the initial COVID-19 outbreak in New York City.

Cancer cells rearrange, copy, and delete their DNA in complex but distinct patterns, according to new research from a multi-institution team led by investigators at Weill Cornell Medicine and the New York Genome Center. The investigators developed sophisticated new algorithms to analyze nearly 3,000 genome sequences from human tumors.

Two Weill Cornell Medicine investigators have received 2017 Clinical Scientist Development Awards from the Doris Duke Charitable Foundation to support their ongoing research projects. 

A newly discovered type of genetic mutation that occurs frequently in cancer cells may provide clues about the disease’s origins and offer new therapeutic targets.

Weill Cornell Medicine (WCM) and the New York Genome Center (NYGC) were...